April 2002 - Volume 13 - Issue 3 - Contributor Index

Alphabetical Search
J
Q
U
X
Author:
Altamura, N.
Author:
Anaissie, E.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Antovic, A.
Author:
Aoshima, K.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Asakura, H.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Badros, A.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Barlogie, B.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Bates, S. M.
Author:
Bertina, R. M.
Author:
Blombäck, M.
Author:
Bremme, K.
Author:
Carr, M. E. Jr.
Author:
Carr, S. L.
Author:
Couturaud, F.
Author:
Cruz, E.
Author:
D'Almeida, V.
Author:
Desikan, R.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Di Chiara, A.
Author:
Dirven, R. J.
Author:
Edlund, M.
Author:
Fassas, A.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Fink, L.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Fioretti, P.
Author:
Fiotti, N.
Author:
Francis, J. L.
Author:
Franco, R. F.
Author:
Fried, G.
Author:
Giansante, C.
Author:
Ginsberg, J. S.
Author:
Goldstein, M.
Author:
Guarnieri, G.
Author:
He, S.
Author:
Heng, C. K.
Author:
Hong, S.
Author:
Ichino, T.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Ito, T.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Kato, M.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Kearon, C.
Author:
Kerbauy, J.
Author:
Leibovitch, I.
Author:
Liu, Y.
Author:
Loewenstein, A.
Author:
Low, P. S.
Author:
Martin, E. J.
Author:
Mehta, P.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Miccio, M.
Author:
Miranda, F.
Author:
Miyamoto, K.-I.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Mizutani, T.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Moore, G. W.
Author:
Morelli, V. M.
Author:
Morishita, E.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Morris, C.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Nakao, S.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Neudorfer, M.
Author:
Ontachi, Y.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Patel, Y.
Author:
Rosing, J.
Author:
Saghafifar, F.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Saha, N.
Author:
Saito, M.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Savidge, G. F.
Author:
Siddiqui, F. A.
Author:
Siegel, E.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Smith, M. P.
Author:
Suga, Y.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Tans, G.
Author:
Toor, A.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Tricot, G.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Vos, H. L.
Author:
Whitfield, D.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Author:
Yamazaki, M.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Yoshida, T.

Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models

Asakura, H.; Ichino, T.; Yoshida, T.; More

Blood Coagulation & Fibrinolysis. 13(3):233-239, April 2002.

Author:
Zago, M. A.
Author:
Zangari, M.

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Zangari, M.; Saghafifar, F.; Anaissie, E.; More

Blood Coagulation & Fibrinolysis. 13(3):187-192, April 2002.

Show: